These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22529293)

  • 1. A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitis.
    Mills JH; Kim DG; Krenz A; Chen JF; Bynoe MS
    J Immunol; 2012 Jun; 188(11):5713-22. PubMed ID: 22529293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis.
    Mills JH; Alabanza LM; Mahamed DA; Bynoe MS
    J Neuroinflammation; 2012 Aug; 9():193. PubMed ID: 22883932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: Never underestimate the power of adenosine in multiple sclerosis.
    Volonté C
    CNS Neurol Disord Drug Targets; 2013 Nov; 12(7):895-6. PubMed ID: 24040797
    [No Abstract]   [Full Text] [Related]  

  • 4. CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis.
    Teige A; Teige I; Lavasani S; Bockermann R; Mondoc E; Holmdahl R; Issazadeh-Navikas S
    J Immunol; 2004 Jan; 172(1):186-94. PubMed ID: 14688325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the adenosine A2A receptor attenuates experimental autoimmune encephalomyelitis and is associated with increased intracellular calcium levels.
    Liu Y; Zou H; Zhao P; Sun B; Wang J; Kong Q; Mu L; Zhao S; Wang G; Wang D; Zhang Y; Zhao J; Yin P; Liu L; Zhao X; Li H
    Neuroscience; 2016 Aug; 330():150-61. PubMed ID: 27217214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of inflammatory responses during myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis is regulated by AKT3 signaling.
    Tsiperson V; Gruber RC; Goldberg MF; Jordan A; Weinger JG; Macian F; Shafit-Zagardo B
    J Immunol; 2013 Feb; 190(4):1528-39. PubMed ID: 23335751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
    Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
    J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
    Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
    Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes.
    Furlan R; Brambilla E; Ruffini F; Poliani PL; Bergami A; Marconi PC; Franciotta DM; Penna G; Comi G; Adorini L; Martino G
    J Immunol; 2001 Aug; 167(3):1821-9. PubMed ID: 11466408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
    Tran EH; Prince EN; Owens T
    J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
    Carboni S; Aboul-Enein F; Waltzinger C; Killeen N; Lassmann H; Peña-Rossi C
    J Neuroimmunol; 2003 Dec; 145(1-2):1-11. PubMed ID: 14644025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
    Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
    Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A4 promotes experimental autoimmune encephalomyelitis by impacting microglial inflammation through TLR4/NF-κB signaling pathway.
    Jingjing H; Tongqian W; Shirong Y; Lan M; Jing L; Shihui M; Haijian Y; Fang Y
    Int Immunopharmacol; 2024 Dec; 142(Pt A):112849. PubMed ID: 39241524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of A2A adenosine receptor in traumatic optic neuropathy.
    Ahmad S; Fatteh N; El-Sherbiny NM; Naime M; Ibrahim AS; El-Sherbini AM; El-Shafey SA; Khan S; Fulzele S; Gonzales J; Liou GI
    J Neuroimmunol; 2013 Nov; 264(1-2):54-64. PubMed ID: 24090652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis.
    Mills JH; Thompson LF; Mueller C; Waickman AT; Jalkanen S; Niemela J; Airas L; Bynoe MS
    Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9325-30. PubMed ID: 18591671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A2A Receptor Signaling in the Immunopathogenesis of Experimental Autoimmune Encephalomyelitis.
    Rajasundaram S
    Front Immunol; 2018; 9():402. PubMed ID: 29559972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.